Cyprus vs France: Reported rate of new cervical cancer cases
Cyprus
6.86 per 100,000 women
in 2017
France
6.89 per 100,000 women
in 2017
Cyprus rank
28th
France rank
27th
Reported rate of new cervical cancer cases over time
- Cyprus
- France
How they compare
France currently reports 6.89 per 100,000 women against 6.86 per 100,000 women in Cyprus, a difference of 0.03 per 100,000 women.
The two have swapped places 6 times across 20 shared years of data; in 1998 it was France ahead.
Cyprus ranks 28th and France ranks 27th of 46 countries.
France has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | France | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.99 per 100,000 women | 7.72 per 100,000 women | 1.73 per 100,000 women | France |
| 2000s | 4.44 per 100,000 women | 6.74 per 100,000 women | 2.3 per 100,000 women | France |
| 2010s | 5.85 per 100,000 women | 6.28 per 100,000 women | 0.4231 per 100,000 women | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Cyprus or France?
- France, at 6.89 per 100,000 women against 6.86 per 100,000 women in Cyprus as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Cyprus and France?
- 0.03 per 100,000 women, with France ahead.
- How many years of comparable data are there for Cyprus and France?
- 20 years are reported by both, from 1998 to 2017.
- How do Cyprus and France rank globally for reported rate of new cervical cancer cases?
- Cyprus ranks 28th and France ranks 27th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) β processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.